BENLYSTA
belimumab
- Strength
- 200 mg/mL
- Form
- Solution
- Class
- B Lymphocyte Stimulator-specific Inhibi…
GlaxoSmithKline LLC
Not stocked by us — reference only
belimumab
Listed by GlaxoSmithKline LLC
| Dosage form | Injection, Powder, Lyophilized, For Solution |
|---|---|
| Route | Intravenous |
| Drug class | B Lymphocyte Stimulator-specific Inhibitor |
| Approval route | BLA — biologic licence |
| NDC code | 49401-102 |
| FDA application | BLA125370 |
| RxNorm concept | 1656395 |
| Package sizes listed | 1 |
| Marketed since | March 2011 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
belimumab
GlaxoSmithKline LLC
Not stocked by us — reference only
belimumab
GlaxoSmithKline LLC
Not stocked by us — reference only
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.